| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | UNITED THERAPEUTICS CORP DEL | 9,300 | 1,221,000 | 0.20% | ||
| 102 | IKANG HEALTHCARE GROUP INC | 75,000 | 1,110,000 | 0.18% | ||
| 103 | INFINITY PHARMACEUTICALS INC | 130,000 | 1,099,000 | 0.18% | ||
| 104 | LABORATORY CORP AMER HLDGS | 10,000 | 1,085,000 | 0.18% | ||
| 105 | CENTENE CORP DEL | 20,000 | 1,085,000 | 0.18% | ||
| 106 | MANNKIND CORP. | 300,000 | 963,000 | 0.16% | ||
| 107 | Esperion Therapeutics Inc | 40,000 | 944,000 | 0.15% | ||
| 108 | EXELIXIS INC | 150,000 | 842,000 | 0.14% | ||
| 109 | TEAM HEALTH HOLDINGS INC | 15,000 | 810,000 | 0.13% | ||
| 110 | RESMED INC | 15,000 | 764,000 | 0.12% | ||
| 111 | ARBUTUS BIOPHARMA CORP | 125,000 | 761,000 | 0.12% | ||
| 112 | ISHARES TR | 2,500 | 758,000 | 0.12% | ||
| 113 | ENDOCYTE INC | 158,000 | 724,000 | 0.12% | ||
| 114 | AFFYMETRIX INCOC-CAP STK CASH MGREFF 4/1/16 1 OLDUSD 14.00 PER SHARE | 80,000 | 683,000 | 0.11% | ||
| 115 | PROTHENA CORP PLC | 15,000 | 680,000 | 0.11% | ||
| 116 | IMPAX LABORATORIES INC | 18,000 | 634,000 | 0.10% | ||
| 117 | ENDOLOGIX INC | 50,000 | 613,000 | 0.10% | ||
| 118 | Juniper Pharmaceuticals Inc | 50,000 | 589,000 | 0.10% | ||
| 119 | INSULET CORPORATION | 22,500 | 583,000 | 0.10% | ||
| 120 | CARDIOVASCULAR SYS INC DEL COM | 30,000 | 475,000 | 0.08% | ||
| 121 | PENUMBRA INC COM | 10,000 | 401,000 | 0.07% | ||
| 122 | IMMUNOGEN INC | 30,000 | 288,000 | 0.05% | ||
| 123 | DYAX CORP COM CVR | 15,000 | 286,000 | 0.05% | ||
| 124 | INNOVIVA INC COM | 35,000 | 251,000 | 0.04% | ||
| 125 | REWALK ROBOTICS LTD | 30,000 | 229,000 | 0.04% | ||
| 126 | WRIGHT MEDICAL GROUP NV | 10,000 | 210,000 | 0.03% | ||
| 127 | XOMA CORP DEL | 225,000 | 169,000 | 0.03% | ||
| 128 | TETRAPHASE PHARMACEUTICALS INC COM | 22,000 | 164,000 | 0.03% | ||
| 129 | Theravance Biopharma Inc | 11,428 | 126,000 | 0.02% | ||
| 130 | GERON CORP | 45,000 | 124,000 | 0.02% | ||
| 131 | CELLADON CORP | 50,000 | 53,000 | 0.01% | ||
| 132 | ASTERIAS BIOTHERAPEUTICS INC COM SER A | 1,875 | 7,000 | 0.00% | ||
| 133 | BIOTIME INC | 2,294 | 2,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-011338, filed 2015.11.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
